Jan 31 0 Pricing Gene Therapies: A Lifeline or Testing the Waters? By Rare Collective | Doug Paul, Rare Collective | No Comments Doug Paul provides his perspective on pricing and reimbursement models for gene therapies. Read More
Jan 24 0 Myth or Fact? “We can do that!” By Rare Collective | Patti Engel | No Comments Patti Engel talks about the importance of having experience in the rare disease space. Read More